Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Arthropathies

imatinib mesylate has been researched along with Arthropathies in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anavim, A; Dennehey, CF; Kong, KM; Moore, JC; Tiong Ong, S1
Blay, JY; El Sayadi, H; Garret, J; Ray-Coquard, I; Thiesse, P1

Other Studies

2 other study(ies) available for imatinib mesylate and Arthropathies

ArticleYear
Multiple joint effusions associated with high-dose imatinib therapy in a patient with chronic myelogenous leukaemia.
    European journal of haematology, 2006, Volume: 76, Issue:5

    Topics: Aged; Benzamides; Dose-Response Relationship, Drug; Edema; Female; Follow-Up Studies; Hip Joint; Humans; Imatinib Mesylate; Joint Diseases; Knee Joint; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Piperazines; Pyrimidines; Treatment Outcome

2006
Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:4

    Topics: Adult; Antineoplastic Agents; Benzamides; Elbow Joint; Female; Giant Cell Tumors; Humans; Imatinib Mesylate; Joint Diseases; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Synovitis, Pigmented Villonodular; Treatment Outcome

2008